Aromatase inhibitor therapy (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aromatase inhibitor therapy (unspecified), covering 2024-12-27 to 2024-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study [Phase 2]